Site-Directed Integration in CHO Cells for Recombinant Protein Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant proteins using CHO cells rely on random integration, which is time-consuming, inefficient, and prone to biological noise, making it difficult to achieve high expression levels and stable clones, and lacks mechanisms to detect or remove unwanted integration events.
Innovation Solution
A novel Site-Directed Integration (SDI) method using a donor vector integrated into a pre-defined genomic location in CHO cells, employing specific DNA enzymes for targeted integration and selection, allowing for the detection and removal of random integration events, thereby reducing biological noise and improving expression efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If random integration approach is used to introduce recombinant protein genes into CHO cell genome, then cells can be selected for integration at active genomic sites, but the process is highly work intensive and time-consuming with large inherent uncertainties and biological variation
Solution Approach 1:
The patent applies preliminary action by pre-modifying the CHO cell genome to include a specific integration site with necessary regulatory elements (promoter, enhancer, polyA signal) before introducing the recombinant gene. This pre-prepared genomic location ensures that when integration occurs, the gene is immediately positioned in an optimal expression environment, eliminating the need for extensive screening and selection processes required by random integration methods.
Solution Approach 2:
The patent uses a specific genomic integration site as an intermediary element between the recombinant gene and the cell's transcriptional machinery. This intermediate site contains all necessary regulatory sequences that mediate high-level expression, acting as a bridge that ensures reliable gene expression without requiring random integration into various genomic locations.
2Quantity of substance
If random integration approach is used, then transfected cells can be obtained, but only around 0.1-1% integrate recombinant DNA and the sub-population is highly heterogeneous in terms of integration locations, copy number and integrity
Solution Approach 1:
The patent applies local quality by creating a specific, localized genomic region with enhanced expression capabilities. Instead of relying on random integration throughout the genome, the recombinant gene is directed to integrate into this specially designed local site that contains optimal regulatory elements, ensuring both high integration efficiency and homogeneous integration characteristics across all transfected cells.
Solution Approach 2:
The patent changes the parameters of the genomic integration site by pre-modifying the cell line to include a specific integration location with controlled copy number (typically single copy) and defined integrity. This parameter control ensures that all integrating cells receive the same quality of integration event, eliminating the heterogeneity observed in random integration approaches.
3Productivity
If targeted integration is used to utilize a pre-identified genomic location, then all cells will contain correctly inserted GOIs with high transcription rate, but challenges remain in generating high enough expression and detecting/removing additional random integration events
Solution Approach 1:
The patent applies preliminary action by pre-establishing cell lines with specific integration sites that include not only the target location but also selectable marker genes and resistance markers. This pre-prepared system allows for straightforward detection and selection of correctly integrated cells, and provides built-in mechanisms to identify and eliminate cells with random integration events, thereby simplifying the overall process despite the targeted approach.
4Productivity
If multiple copies of expression vector are integrated through simultaneous transfection, then protein expression may be improved, but cells will contain integrated copies from more than one gene cassette design making comparison difficult
Solution Approach 1:
The patent applies local quality by directing all integrations to a single, specific genomic location rather than allowing random integration throughout the genome. This ensures that even when multiple copies integrate, they all do so at the same controlled site with identical regulatory elements, enabling reliable comparison between different gene cassette designs while maintaining the ability to achieve high expression through multiple copies at the optimized location.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces the time and effort required for Cell Line Development, enhances the control over recombinant gene integration, and ensures high and stable protein expression by selectively integrating the donor vector into a pre-defined genomic location, minimizing unwanted sequences and biological variation.
Implementation Method 1
the presence of the first DNA enzyme enables recombination between the nucleic acid sequence I2 of the donor vector and the nucleic acid sequence I1 present in the pre-defined genomic location of the cell
Implementation Method 2
the presence of the second DNA enzyme enables recombination between the nucleic acid sequences E1 and E2
Data Source
AI summary
The present disclosure relates to a method for targeted integration of a donor vector into a specific pre-defined genomic location of an isolated eukaryotic host cell. The vector and host cell together comprise nucleic acid components allowing for the selection of cells having integrated the donor vector into the pre-defined genomic location of the host cell. In addition, it provides for the identification of any random integrations of the donor vector(s) into other parts of the host cell genome. Once identified, such cells present an excellent alternative for subsequent recombinant protein production.